Literature DB >> 638188

Similarity of antigelatin factor and cold insoluble globulin.

W Dessau, F Jilek, B C Adelmann, H Hörmann.   

Abstract

Antigelatin factor, a protein capable of complexing denatured collagen, was separated from human serum by adsorption onto immobilized collagen. Antiserum raised against the material binding to denatured collagen permitted the development of a radioassay for the determination of antigelatin factor in which the complex of antigelatin factor and denatured 125I-labeled collagen is precipitated with this antiserum. Further purification of antigelatin factor was achieved by chromatography on DEAE-cellulose yielding an electrophoretically homogeneous protein. Its migration rate in dodecyl sulfate-polyacrylamide gel electrophoresis was identical with that of cold insoluble globulin (molecular weight approx. 440 000) prepared from human plasma by a published procedure amended by DEAE-cellulose chromatography. Reduction of disulfide bonds yielded subunits of molecular weight approx. 220 000, indistinguishable from those of cold insoluble globulin. The amino acid composition of both proteins was very similar. Immunological identity of both proteins was demonstrated by gel diffusion against monospecific anti-cold insoluble globulin antiserum. Closely related binding curves were obtained if denatured 125I-labeled collagen was reacted with increasing amounts of either cold insoluble globulin or antigelatin factor and the complexes formed were precipitated with anti-cold insoluble globulin antiserum. In addition, antigelatin factor and cold insoluble globulin mediated the fixation of denatured 125I-labeled collagen to trypsinized macrophages in the same way. Therefore, it is concluded that antigelatin factor and cold insoluble globulin are identical or very closely related proteins.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638188     DOI: 10.1016/0005-2795(78)90566-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Generation and characterization of a neutrophil-derived inhibitor of fibroblast chemotaxis.

Authors:  H Mensing; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.

Authors:  D F Mosher; P E Schad
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

3.  Interaction of viral envelope glycoproteins with fibronectin.

Authors:  I Julkunen; A Hautanen; J Keski-Oja
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

4.  The role of fibronectin in the cryoprecipitation of monoclonal cryoglobulins.

Authors:  J Strevey; A D Beaulieu; C Ménard; J P Valet; L Latulippe; J Hébert
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

5.  Studies in vivo and in vitro on the uptake and degradation of soluble collagen alpha 1(I) chains in rat liver endothelial and Kupffer cells.

Authors:  B Smedsrød; S Johansson; H Pertoft
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

6.  Polypeptide heterogeneity of hamster and calf fibronectins.

Authors:  S D Pena; G Mills; R C Hughes; J D Aplin
Journal:  Biochem J       Date:  1980-08-01       Impact factor: 3.857

7.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

8.  Fibronectin--mediator between cells and connective tissue.

Authors:  H Hörmann
Journal:  Klin Wochenschr       Date:  1982-10-15

9.  Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.

Authors:  D C Deno; M H McCafferty; T M Saba; F A Blumenstock
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

10.  Dissociation of fibronectin from gelatin-agarose by amino compounds.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1978-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.